Medpace Holdings Price to Free Cash Flow Ratio 2014-2025 | MEDP
Historical price to free cash flow ratio values for Medpace Holdings (MEDP) since 2014.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Medpace Holdings Price to Free Cash Flow Ratio Historical Data |
Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
2025-05-02 |
305.11 |
|
17.96 |
2025-03-31 |
304.69 |
$16.99 |
17.93 |
2024-12-31 |
332.23 |
$17.88 |
18.59 |
2024-09-30 |
333.80 |
$16.71 |
19.98 |
2024-06-30 |
411.85 |
$15.69 |
26.25 |
2024-03-31 |
404.15 |
$14.86 |
27.19 |
2023-12-31 |
306.53 |
$12.46 |
24.60 |
2023-09-30 |
242.13 |
$11.37 |
21.29 |
2023-06-30 |
240.17 |
$11.38 |
21.11 |
2023-03-31 |
188.05 |
$11.61 |
16.20 |
2022-12-31 |
212.41 |
$10.43 |
20.37 |
2022-09-30 |
157.17 |
$8.55 |
18.37 |
2022-06-30 |
149.67 |
$7.02 |
21.33 |
2022-03-31 |
163.59 |
$5.91 |
27.69 |
2021-12-31 |
217.64 |
$6.24 |
34.90 |
2021-09-30 |
189.28 |
$7.21 |
26.24 |
2021-06-30 |
176.63 |
$6.78 |
26.06 |
2021-03-31 |
164.05 |
$6.23 |
26.34 |
2020-12-31 |
139.20 |
$6.03 |
23.09 |
2020-09-30 |
111.75 |
$4.82 |
23.19 |
2020-06-30 |
93.02 |
$5.00 |
18.59 |
2020-03-31 |
73.38 |
$5.20 |
14.12 |
2019-12-31 |
84.06 |
$4.90 |
17.17 |
2019-09-30 |
84.04 |
$4.50 |
18.67 |
2019-06-30 |
65.42 |
$4.31 |
15.18 |
2019-03-31 |
58.97 |
$4.12 |
14.31 |
2018-12-31 |
52.93 |
$3.81 |
13.90 |
2018-09-30 |
59.91 |
$3.43 |
17.46 |
2018-06-30 |
43.00 |
$3.07 |
14.03 |
2018-03-31 |
34.91 |
$2.80 |
12.46 |
2017-12-31 |
36.26 |
$2.15 |
16.86 |
2017-09-30 |
31.90 |
$2.23 |
14.30 |
2017-06-30 |
29.00 |
$2.73 |
10.61 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical Services |
$8.769B |
$2.109B |
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
|